Goldman Sachs’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.6M Sell
76,000
-115,800
-60% -$27M ﹤0.01% 2500
2025
Q4
$39.7M Buy
191,800
+54,900
+40% +$10.9M ﹤0.01% 1701
2025
Q3
$25.4M Sell
136,900
-32,900
-19% -$5.64M ﹤0.01% 2023
2025
Q2
$25.9M Buy
169,800
+110,600
+187% +$17M ﹤0.01% 1892
2025
Q1
$9.82M Sell
59,200
-14,100
-19% -$2.21M ﹤0.01% 2716
2024
Q4
$10.6M Buy
73,300
+15,200
+26% +$2.36M ﹤0.01% 2745
2024
Q3
$9.42M Sell
58,100
-179,100
-76% -$28.5M ﹤0.01% 2795
2024
Q2
$34.7M Buy
237,200
+14,200
+6% +$2.11M 0.01% 1431
2024
Q1
$35.3M Sell
223,000
-98,500
-31% -$15.7M 0.01% 1402
2023
Q4
$50.4M Buy
321,500
+144,300
+81% +$22.1M 0.01% 1184
2023
Q3
$27.6M Buy
177,200
+50,000
+39% +$8.25M 0.01% 1523
2023
Q2
$21.1M Buy
127,200
+86,200
+210% +$13.9M ﹤0.01% 1802
2023
Q1
$6.36M Sell
41,000
-260,500
-86% -$42.1M ﹤0.01% 2826
2022
Q4
$53.3M Sell
301,500
-43,000
-12% -$7.42M 0.01% 1121
2022
Q3
$56.3M Buy
344,500
+80,700
+31% +$13.7M 0.01% 1032
2022
Q2
$46.8M Sell
263,800
-107,600
-29% -$19.2M 0.01% 1168
2022
Q1
$65.8M Sell
371,400
-84,000
-18% -$14.3M 0.01% 1058
2021
Q4
$77.9M Sell
455,400
-9,400
-2% -$1.54M 0.02% 972
2021
Q3
$75.1M Sell
464,800
-60,800
-12% -$10.4M 0.02% 941
2021
Q2
$86.6M Buy
525,600
+288,500
+122% +$47.8M 0.02% 826
2021
Q1
$39M Buy
237,100
+40,600
+21% +$6.57M 0.01% 1372
2020
Q4
$30.9M Buy
196,500
+52,600
+37% +$7.76M 0.01% 1499
2020
Q3
$21.4M Buy
143,900
+38,200
+36% +$5.65M 0.01% 1690
2020
Q2
$14.9M Sell
105,700
-52,200
-33% -$7.61M ﹤0.01% 1927
2020
Q1
$20.7M Sell
157,900
-59,200
-27% -$8.4M 0.01% 1477
2019
Q4
$31.7M Sell
217,100
-29,600
-12% -$4.01M 0.01% 1487
2019
Q3
$31.9M Sell
246,700
-90,000
-27% -$11.9M 0.01% 1427
2019
Q2
$46.9M Buy
336,700
+16,800
+5% +$2.33M 0.01% 1181
2019
Q1
$44.7M Buy
319,900
+150,600
+89% +$20.2M 0.01% 1222
2018
Q4
$21.8M Buy
169,300
+12,800
+8% +$1.79M 0.01% 1735
2018
Q3
$21.6M Sell
156,500
-302,800
-66% -$40.2M 0.01% 1851
2018
Q2
$55.7M Sell
459,300
-223,200
-33% -$27.8M 0.02% 1129
2018
Q1
$87.5M Sell
682,500
-336,900
-33% -$45.5M 0.02% 856
2017
Q4
$142M Buy
1,019,400
+265,000
+35% +$36.9M 0.03% 615
2017
Q3
$98.1M Sell
754,400
-115,800
-13% -$15.4M 0.02% 818
2017
Q2
$115M Sell
870,200
-12,800
-1% -$1.63M 0.03% 686
2017
Q1
$110M Buy
883,000
+164,600
+23% +$19.7M 0.03% 698
2016
Q4
$82.8M Sell
718,400
-246,800
-26% -$28.5M 0.02% 907
2016
Q3
$114M Sell
965,200
-356,000
-27% -$43.2M 0.03% 642
2016
Q2
$160M Sell
1,321,200
-600,800
-31% -$68.3M 0.05% 440
2016
Q1
$208M Buy
1,922,000
+180,000
+10% +$18.6M 0.07% 326
2015
Q4
$179M Sell
1,742,000
-985,200
-36% -$99.1M 0.06% 394
2015
Q3
$255M Buy
2,727,200
+1,277,300
+88% +$124M 0.09% 230
2015
Q2
$141M Buy
1,449,900
+840,000
+138% +$84.1M 0.04% 483
2015
Q1
$61.4M Sell
609,900
-112,600
-16% -$11.5M 0.02% 947
2014
Q4
$75.6M Buy
722,500
+7,500
+1% +$790K 0.02% 832
2014
Q3
$76.2M Buy
715,000
+4,300
+0.6% +$446K 0.02% 788
2014
Q2
$74.4M Sell
710,700
-165,600
-19% -$16.7M 0.02% 847
2014
Q1
$86.1M Sell
876,300
-1,295,100
-60% -$120M 0.03% 685
2013
Q4
$199M Buy
2,171,400
+1,017,400
+88% +$93.8M 0.07% 332
2013
Q3
$100M Buy
1,154,000
+252,800
+28% +$22.7M 0.04% 599
2013
Q2
$77.4M Buy
+901,200
New +$76.5M 0.03% 656

Other funds holding JNJ

Goldman Sachs's JNJ Position: Q1 2026 in Review

Goldman Sachs increased its Johnson & Johnson (JNJ) stake by 11% in Q1 2026, buying an estimated $400M and bringing the position to 18,057,047 shares worth $4.41B. The position accounts for 0.51% of the portfolio, ranked #24.

Goldman Sachs first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Goldman Sachs held 18,057,047 shares of Johnson & Johnson worth $4.41B as of Q1 2026.
  • Goldman Sachs bought 1,716,975 Johnson & Johnson shares in Q1 2026, an estimated $400M.
  • Johnson & Johnson made up 0.51% of Goldman Sachs's portfolio in Q1 2026, its #24 holding.
  • Goldman Sachs first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.